These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 17548579)

  • 21. Heterozygous carriage of a dysfunctional Toll-like receptor 9 allele affects CpG oligonucleotide responses in B cells.
    Knezević J; Pavlinić D; Rose WA; Leifer CA; Bendelja K; Gabrilovac J; Parcina M; Lauc G; Kubarenko AV; Petricevic B; Vrbanec D; Bulat-Kardum L; Bekeredjian-Ding I; Pavelić J; Dembić Z; Weber AN
    J Biol Chem; 2012 Jul; 287(29):24544-53. PubMed ID: 22613717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CXCL14 Acts as a Specific Carrier of CpG DNA into Dendritic Cells and Activates Toll-like Receptor 9-mediated Adaptive Immunity.
    Tanegashima K; Takahashi R; Nuriya H; Iwase R; Naruse N; Tsuji K; Shigenaga A; Otaka A; Hara T
    EBioMedicine; 2017 Oct; 24():247-256. PubMed ID: 28928016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Size-dependent attenuation of TLR9 signaling by gold nanoparticles in macrophages.
    Tsai CY; Lu SL; Hu CW; Yeh CS; Lee GB; Lei HY
    J Immunol; 2012 Jan; 188(1):68-76. PubMed ID: 22156340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory mediators are inhibited by a taurine metabolite in CpG oligodeoxynucleotide and IFN-r activated macrophage cell line.
    Kim BS; Spinner DS; Kascsak RJ; Park SY; Cho IS; Schuller-Levis G; Park E
    J Drugs Dermatol; 2013 May; 12(5):551-7. PubMed ID: 23652950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mannose receptor 1 mediates cellular uptake and endosomal delivery of CpG-motif containing oligodeoxynucleotides.
    Moseman AP; Moseman EA; Schworer S; Smirnova I; Volkova T; von Andrian U; Poltorak A
    J Immunol; 2013 Dec; 191(11):5615-24. PubMed ID: 24184555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytidine-phosphate-guanosine oligonucleotides induce interleukin-8 production through activation of TLR9, MyD88, NF-κB, and ERK pathways in odontoblast cells.
    He W; Zhang Y; Zhang J; Yu Q; Wang P; Wang Z; Smith AJ
    J Endod; 2012 Jun; 38(6):780-5. PubMed ID: 22595112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TLR9 is localized in the endoplasmic reticulum prior to stimulation.
    Leifer CA; Kennedy MN; Mazzoni A; Lee C; Kruhlak MJ; Segal DM
    J Immunol; 2004 Jul; 173(2):1179-83. PubMed ID: 15240708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deoxynucleic acids from Cryptococcus neoformans activate myeloid dendritic cells via a TLR9-dependent pathway.
    Nakamura K; Miyazato A; Xiao G; Hatta M; Inden K; Aoyagi T; Shiratori K; Takeda K; Akira S; Saijo S; Iwakura Y; Adachi Y; Ohno N; Suzuki K; Fujita J; Kaku M; Kawakami K
    J Immunol; 2008 Mar; 180(6):4067-74. PubMed ID: 18322216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
    Abu-Rish EY; Amrani Y; Browning MJ
    Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular cloning and characterization of a novel anti-TLR9 intrabody.
    Reimer E; Somplatzki S; Zegenhagen D; Hänel S; Fels A; Bollhorst T; Hovest LG; Bauer S; Kirschning CJ; Böldicke T
    Cell Mol Biol Lett; 2013 Sep; 18(3):433-46. PubMed ID: 23893288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel antagonist of TLR9 blocking all classes of immunostimulatory CpG-ODNs.
    Li Y; Cao H; Wang N; Xiang Y; Lu Y; Zhao K; Zheng J; Zhou H
    Vaccine; 2011 Mar; 29(11):2193-8. PubMed ID: 21036131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired toll-like receptor 9 expression in alveolar macrophages with no sensitivity to CpG DNA.
    Suzuki K; Suda T; Naito T; Ide K; Chida K; Nakamura H
    Am J Respir Crit Care Med; 2005 Apr; 171(7):707-13. PubMed ID: 15640365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HMGB1 was a pivotal synergistic effecor for CpG oligonucleotide to enhance the progression of human lung cancer cells.
    Wang C; Fei G; Liu Z; Li Q; Xu Z; Ren T
    Cancer Biol Ther; 2012 Jul; 13(9):727-36. PubMed ID: 22617774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
    Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
    J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific siRNA downregulated TLR9 and altered cytokine expression pattern in macrophage after CpG DNA stimulation.
    Qiao B; Li B; Yang X; Zhang H; Chu Y; Wang Y; Xiong S
    Cell Mol Immunol; 2005 Apr; 2(2):130-5. PubMed ID: 16191419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
    Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toll like receptor 9 antagonism modulates spinal cord neuronal function and survival: Direct versus astrocyte-mediated mechanisms.
    Acioglu C; Mirabelli E; Baykal AT; Ni L; Ratnayake A; Heary RF; Elkabes S
    Brain Behav Immun; 2016 Aug; 56():310-24. PubMed ID: 27044334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE.
    Tian J; Avalos AM; Mao SY; Chen B; Senthil K; Wu H; Parroche P; Drabic S; Golenbock D; Sirois C; Hua J; An LL; Audoly L; La Rosa G; Bierhaus A; Naworth P; Marshak-Rothstein A; Crow MK; Fitzgerald KA; Latz E; Kiener PA; Coyle AJ
    Nat Immunol; 2007 May; 8(5):487-96. PubMed ID: 17417641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Innate immune responses in lupus-prone Palmerston North mice: differential responses to LPS and bacterial DNA/CpG oligonucleotides.
    Lenert P; Goeken A; Handwerger BS; Ashman RF
    J Clin Immunol; 2003 May; 23(3):202-13. PubMed ID: 12797542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TLR9 ligand CpG-ODN applied to the injured mouse cornea elicits retinal inflammation.
    Chinnery HR; McLenachan S; Binz N; Sun Y; Forrester JV; Degli-Esposti MA; Pearlman E; McMenamin PG
    Am J Pathol; 2012 Jan; 180(1):209-20. PubMed ID: 22085974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.